Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 532

1.

Lithium or an atypical antipsychotic drug in the management of treatment-resistant depression: a systematic review and economic evaluation.

Edwards SJ, Hamilton V, Nherera L, Trevor N.

Health Technol Assess. 2013 Nov;17(54):1-190. doi: 10.3310/hta17540. Review.

2.

A systematic review and economic model of the clinical effectiveness and cost-effectiveness of interventions for preventing relapse in people with bipolar disorder.

Soares-Weiser K, Bravo Vergel Y, Beynon S, Dunn G, Barbieri M, Duffy S, Geddes J, Gilbody S, Palmer S, Woolacott N.

Health Technol Assess. 2007 Oct;11(39):iii-iv, ix-206. Review.

3.

A rapid and systematic review of the clinical effectiveness and cost-effectiveness of topotecan for ovarian cancer.

Forbes C, Shirran L, Bagnall AM, Duffy S, ter Riet G.

Health Technol Assess. 2001;5(28):1-110. Review.

4.

Pharmacologic approaches to treatment resistant depression: Evidences and personal experience.

Tundo A, de Filippis R, Proietti L.

World J Psychiatry. 2015 Sep 22;5(3):330-41. doi: 10.5498/wjp.v5.i3.330.

5.

Antidepressant treatment for postnatal depression.

Molyneaux E, Howard LM, McGeown HR, Karia AM, Trevillion K.

Cochrane Database Syst Rev. 2014 Sep 11;(9):CD002018. doi: 10.1002/14651858.CD002018.pub2. Review.

PMID:
25211400
6.

Antidepressants for people with epilepsy and depression.

Maguire MJ, Weston J, Singh J, Marson AG.

Cochrane Database Syst Rev. 2014 Dec 3;(12):CD010682. doi: 10.1002/14651858.CD010682.pub2. Review.

PMID:
25464360
7.

The clinical effectiveness and cost-effectiveness of bariatric (weight loss) surgery for obesity: a systematic review and economic evaluation.

Picot J, Jones J, Colquitt JL, Gospodarevskaya E, Loveman E, Baxter L, Clegg AJ.

Health Technol Assess. 2009 Sep;13(41):1-190, 215-357, iii-iv. doi: 10.3310/hta13410. Review.

8.

Fluoxetine versus other types of pharmacotherapy for depression.

Magni LR, Purgato M, Gastaldon C, Papola D, Furukawa TA, Cipriani A, Barbui C.

Cochrane Database Syst Rev. 2013 Jul 17;(7):CD004185. Review.

PMID:
24353997
9.

Systematic review and economic modelling of the effectiveness and cost-effectiveness of non-surgical treatments for women with stress urinary incontinence.

Imamura M, Abrams P, Bain C, Buckley B, Cardozo L, Cody J, Cook J, Eustice S, Glazener C, Grant A, Hay-Smith J, Hislop J, Jenkinson D, Kilonzo M, Nabi G, N'Dow J, Pickard R, Ternent L, Wallace S, Wardle J, Zhu S, Vale L.

Health Technol Assess. 2010 Aug;14(40):1-188, iii-iv. doi: 10.3310/hta14400. Review.

10.

Adefovir dipivoxil and pegylated interferon alfa-2a for the treatment of chronic hepatitis B: a systematic review and economic evaluation.

Shepherd J, Jones J, Takeda A, Davidson P, Price A.

Health Technol Assess. 2006 Aug;10(28):iii-iv, xi-xiv, 1-183. Review.

11.

Clinical effectiveness and cost-effectiveness of second- and third-generation left ventricular assist devices as either bridge to transplant or alternative to transplant for adults eligible for heart transplantation: systematic review and cost-effectiveness model.

Sutcliffe P, Connock M, Pulikottil-Jacob R, Kandala NB, Suri G, Gurung T, Grove A, Shyangdan D, Briscoe S, Maheswaran H, Clarke A.

Health Technol Assess. 2013 Nov;17(53):1-499, v-vi. doi: 10.3310/hta17530. Review.

12.

Paroxetine versus other anti-depressive agents for depression.

Purgato M, Papola D, Gastaldon C, Trespidi C, Magni LR, Rizzo C, Furukawa TA, Watanabe N, Cipriani A, Barbui C.

Cochrane Database Syst Rev. 2014 Apr 3;(4):CD006531. doi: 10.1002/14651858.CD006531.pub2. Review.

PMID:
24696195
13.

A systematic review and economic evaluation of the clinical effectiveness and cost-effectiveness of aldosterone antagonists for postmyocardial infarction heart failure.

McKenna C, Burch J, Suekarran S, Walker S, Bakhai A, Witte K, Harden M, Wright K, Woolacott N, Lorgelly P, Fenwick L, Palmer S.

Health Technol Assess. 2010 May;14(24):1-162. doi: 10.3310/hta14240. Review.

14.

Effectiveness and cost-effectiveness of computer and other electronic aids for smoking cessation: a systematic review and network meta-analysis.

Chen YF, Madan J, Welton N, Yahaya I, Aveyard P, Bauld L, Wang D, Fry-Smith A, Munaf├▓ MR.

Health Technol Assess. 2012;16(38):1-205, iii-v. doi: 10.3310/hta16380. Review.

15.

Randomised controlled trial to determine the clinical effectiveness and cost-effectiveness of selective serotonin reuptake inhibitors plus supportive care, versus supportive care alone, for mild to moderate depression with somatic symptoms in primary care: the THREAD (THREshold for AntiDepressant response) study.

Kendrick T, Chatwin J, Dowrick C, Tylee A, Morriss R, Peveler R, Leese M, McCrone P, Harris T, Moore M, Byng R, Brown G, Barthel S, Mander H, Ring A, Kelly V, Wallace V, Gabbay M, Craig T, Mann A.

Health Technol Assess. 2009 Apr;13(22):iii-iv, ix-xi, 1-159. doi: 10.3310/hta13220.

16.

Repetitive transcranial magnetic stimulation for the treatment of major depressive disorder: an evidence-based analysis.

Health Quality Ontario.

Ont Health Technol Assess Ser. 2004;4(7):1-98. Epub 2004 Jun 1.

17.

A systematic review and economic evaluation of the use of tumour necrosis factor-alpha (TNF-╬▒) inhibitors, adalimumab and infliximab, for Crohn's disease.

Dretzke J, Edlin R, Round J, Connock M, Hulme C, Czeczot J, Fry-Smith A, McCabe C, Meads C.

Health Technol Assess. 2011 Feb;15(6):1-244. doi: 10.3310/hta15060. Review.

18.

Management of frozen shoulder: a systematic review and cost-effectiveness analysis.

Maund E, Craig D, Suekarran S, Neilson A, Wright K, Brealey S, Dennis L, Goodchild L, Hanchard N, Rangan A, Richardson G, Robertson J, McDaid C.

Health Technol Assess. 2012;16(11):1-264. doi: 10.3310/hta16110. Review.

19.

The effectiveness and cost-effectiveness of donepezil, galantamine, rivastigmine and memantine for the treatment of Alzheimer's disease (review of Technology Appraisal No. 111): a systematic review and economic model.

Bond M, Rogers G, Peters J, Anderson R, Hoyle M, Miners A, Moxham T, Davis S, Thokala P, Wailoo A, Jeffreys M, Hyde C.

Health Technol Assess. 2012;16(21):1-470. doi: 10.3310/hta16210. Review.

20.

Systematic review and modelling of the cost-effectiveness of cardiac magnetic resonance imaging compared with current existing testing pathways in ischaemic cardiomyopathy.

Campbell F, Thokala P, Uttley LC, Sutton A, Sutton AJ, Al-Mohammad A, Thomas SM.

Health Technol Assess. 2014 Sep;18(59):1-120. doi: 10.3310/hta18590. Review.

Items per page

Supplemental Content

Write to the Help Desk